Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
多基因盐敏感性高血压动脉僵硬度的遗传机制
基本信息
- 批准号:8292163
- 负责人:
- 金额:$ 40.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-20 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAgeAnimal ModelArteriesBlood PressureCardiovascular DiseasesCardiovascular systemCarotid ArteriesChronic Kidney FailureClinical ResearchCollagenCoronary heart diseaseDataDevelopmentDiseaseElastinEnvironmentEpigenetic ProcessEssential HypertensionEtiologyFemaleGene ExpressionGenesGeneticGenetic Predisposition to DiseaseGoalsHousingHypertensionImplantInterventionInvestigationLeadLifeMeasurementMeasuresModelingMolecularMolecular GeneticsMonitorOrganOutcomePathway interactionsPhysiologic pulsePlayPredispositionPrevention strategyQuantitative Trait LociRattusResearchResearch ProposalsResistanceResolutionRiskRoleSodium ChlorideStrokeStructureSusceptibility GeneSystemTestingTimeTransgenic OrganismsUltrasonographyWorkarterial stiffnessexperiencegene environment interactiongenetic linkage analysisgenetic variantgenome wide association studygenome-wide linkageinsightmalemeetingsminiaturizenanonew technologypublic health relevancesalt sensitivesexsystems researchtrait
项目摘要
DESCRIPTION (provided by applicant): Our long term goal is to elucidate the etiology of essential or polygenic hypertension with a focus on the elucidation of genetic variants that underlie hypertension susceptibility and gene-environment interactions which exacerbate hypertension susceptibility and end-organ disease. The emerging importance of arterial stiffening measured as pulse wave velocity or PWV in clinical studies demonstrating the association of increased PWV and cardiovascular outcomes (stroke, coronary heart disease, and chronic kidney disease) has pinpointed a likely robust predictive parameter, but at the same time highlighted the need for animal model studies to address mechanisms. Accordingly, this research proposal focuses on RFA-stated goals: #1) "to explore the temporal relationship between arterial stiffening and the development of hypertension in an animal model", and #2) to conduct "cellular and molecular investigation of mechanisms that lead to conduit artery stiffening in the context of (essential/polygenic) hypertension". To accomplish this we have prioritized the following specific aims: Aim 1. Examine the temporal relation between large artery stiffening (measured as aortic PWV and strain, carotid PWV and strain via high-resolution ultrasonography), and the development of salt-sensitive hypertension (measured via non-stress 24/7 telemetric BP analysis of SBP, DBP, MAP and PP) and stroke in both male and female stroke-prone Dahl S rats. Aim 2. Define the temporal and spatial changes in aortic and carotid artery structure in all three vessel layers, along with putative gene expression changes that underlie Na-induced exacerbation and progression of arterial stiffness along the disease course of hypertension and its end-organ complications. Aim 3. Elucidate the role of genetic mechanisms in the causation of arterial stiffness in the context of polygenic salt-sensitive hypertension via genome-wide scan of F2[Dahl S x Dahl R]-intercross male and female rats identifying common and sex-specific quantitative trait loci (QTLs) that contribute to arterial stiffness individually or interactively. Altogether, these three aims will elucidate the relationship of aortic and carotid arterial stiffness to polygenic (essential) hypertension and stroke in a Na-induced stroke-prone hypertension rat model, as well as give insight into causal cellular, molecular, and genetic mechanisms.
PUBLIC HEALTH RELEVANCE: The emerging importance of arterial stiffening in clinical studies demonstrating the association of increased arterial stiffness and cardiovascular diseases like hypertension, stroke, coronary heart disease, and chronic kidney disease, has pinpointed a likely robust predictive parameter of these diseases. Accordingly, our research will help to elucidate the relationship of arterial stiffness to hypertension and give insight into causal mechanisms of abnormal arterial stiffness. This information will help to establish new intervention and prevention strategies for essential hypertension and its associated target organ complications like stroke, coronary heart disease, and chronic kidney disease.
描述(由申请人提供):我们的长期目标是阐明原发性或多基因高血压的病因,重点是阐明高血压易感性的遗传变异和加剧高血压易感性和终末器官疾病的基因-环境相互作用。在临床研究中,以脉搏波速度或PWV测量的动脉硬化的重要性日益显现,证明了PWV增加与心血管结局(卒中、冠心病和慢性肾病)的相关性,这已经确定了一个可能的稳健预测参数,但同时强调了动物模型研究解决机制的必要性。因此,本研究提案侧重于RFA规定的目标:#1)“探索动物模型中动脉硬化与高血压发展之间的时间关系”,以及#2)进行“在(原发性/多基因)高血压背景下导致管道动脉硬化的机制的细胞和分子研究”。为了实现这一目标,我们优先考虑了以下具体目标:目标1。检查大动脉硬化(通过高分辨率超声检查测量为主动脉PWV和应变,颈动脉PWV和应变)与盐敏感性高血压(通过SBP,DBP,MAP和PP的非应激24/7遥测BP分析测量)和卒中之间的时间关系,在雄性和雌性卒中易感Dahl S大鼠中。目标二。定义所有三个血管层中主动脉和颈动脉结构的时间和空间变化,沿着假定的基因表达变化,这些变化是钠诱导的动脉僵硬度恶化和进展的基础,沿着高血压及其终末器官并发症的病程。目标3。通过对F2代[Dahl S x Dahl R]杂交雄性和雌性大鼠进行全基因组扫描,确定单独或交互作用导致动脉僵硬度的常见和性别特异性数量性状位点(QTL),阐明遗传机制在多基因盐敏感性高血压背景下动脉僵硬度病因中的作用。总之,这三个目标将阐明主动脉和颈动脉僵硬度的关系,多基因(原发性)高血压和中风在钠诱导的中风倾向的高血压大鼠模型,以及深入了解因果细胞,分子和遗传机制。
公共卫生相关性:在临床研究中,动脉硬化的重要性日益显现,证明了动脉硬化增加与心血管疾病(如高血压、中风、冠心病和慢性肾病)的相关性,这已经确定了这些疾病的一个可能的稳健预测参数。因此,我们的研究将有助于阐明动脉僵硬度与高血压的关系,并深入了解异常动脉僵硬度的因果机制。这些信息将有助于建立新的干预和预防策略,原发性高血压及其相关的靶器官并发症,如中风,冠心病和慢性肾脏疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NELSON RUIZ-OPAZO其他文献
NELSON RUIZ-OPAZO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NELSON RUIZ-OPAZO', 18)}}的其他基金
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
多基因盐敏感性高血压动脉僵硬度的遗传机制
- 批准号:
8484427 - 财政年份:2010
- 资助金额:
$ 40.22万 - 项目类别:
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
多基因盐敏感性高血压动脉僵硬度的遗传机制
- 批准号:
8015867 - 财政年份:2010
- 资助金额:
$ 40.22万 - 项目类别:
Genetic mechanisms of arterial stiffness in polygenic salt-sensitive hypertension
多基因盐敏感性高血压动脉僵硬度的遗传机制
- 批准号:
8145199 - 财政年份:2010
- 资助金额:
$ 40.22万 - 项目类别:
Functional characterization of ATP1A1 and DEspR variants associated with essentia
与 essentia 相关的 ATP1A1 和 DEspR 变体的功能表征
- 批准号:
7701362 - 财政年份:2009
- 资助金额:
$ 40.22万 - 项目类别:
Functional characterization of ATP1A1 and DEspR variants associated with essentia
与 essentia 相关的 ATP1A1 和 DEspR 变体的功能表征
- 批准号:
7932877 - 财政年份:2009
- 资助金额:
$ 40.22万 - 项目类别:
Gender-specific genetic determinants of hypertension and end organ disease
高血压和终末器官疾病的性别特异性遗传决定因素
- 批准号:
7461206 - 财政年份:2008
- 资助金额:
$ 40.22万 - 项目类别:
Gender-specific genetic determinants of hypertension and end organ disease
高血压和终末器官疾病的性别特异性遗传决定因素
- 批准号:
7676110 - 财政年份:2008
- 资助金额:
$ 40.22万 - 项目类别:
Gender-specific genetic determinants of hypertension and end organ disease
高血压和终末器官疾病的性别特异性遗传决定因素
- 批准号:
7888204 - 财政年份:2008
- 资助金额:
$ 40.22万 - 项目类别:
Molecular Genetics of the ET-1/AngII Receptor
ET-1/AngII 受体的分子遗传学
- 批准号:
6459132 - 财政年份:2002
- 资助金额:
$ 40.22万 - 项目类别:
Molecular Genetics of the ET-1/AngII Receptor
ET-1/AngII 受体的分子遗传学
- 批准号:
6852637 - 财政年份:2002
- 资助金额:
$ 40.22万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
- 批准号:
488140-2016 - 财政年份:2018
- 资助金额:
$ 40.22万 - 项目类别:
Postdoctoral Fellowships
The Structural and Metabolic Changes Associated with Ependymal Layer Disruption in the Age Continuum of Hydrocephalus - A Human and Animal Model Study
脑积水年龄连续体中与室管膜层破坏相关的结构和代谢变化 - 人类和动物模型研究
- 批准号:
376678 - 财政年份:2017
- 资助金额:
$ 40.22万 - 项目类别:
Studentship Programs
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
- 批准号:
488140-2016 - 财政年份:2017
- 资助金额:
$ 40.22万 - 项目类别:
Postdoctoral Fellowships
Effect of tea flavonoids and low dose estrogen on bone metabolism in an animal model for age-related bone loss
茶黄酮和低剂量雌激素对年龄相关性骨质流失动物模型骨代谢的影响
- 批准号:
488140-2016 - 财政年份:2016
- 资助金额:
$ 40.22万 - 项目类别:
Postdoctoral Fellowships
Animal model of impaired autoregulation for study of age related vascular cognitive impairment
用于研究年龄相关血管认知障碍的自动调节受损动物模型
- 批准号:
9197938 - 财政年份:2016
- 资助金额:
$ 40.22万 - 项目类别:
The domestic cat as an animal model for age-related neurofibrillary tangles
家猫作为年龄相关神经原纤维缠结的动物模型
- 批准号:
24780283 - 财政年份:2012
- 资助金额:
$ 40.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Identification of candidate genes responsible for an increased susceptibility of age-related macular degeneration using an animal model and its application to gene diagnosis.
使用动物模型鉴定导致年龄相关性黄斑变性易感性增加的候选基因及其在基因诊断中的应用。
- 批准号:
22591939 - 财政年份:2010
- 资助金额:
$ 40.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MT1-MMP-based Animal Model of Age-related Macular Degeneration (AMD)
基于 MT1-MMP 的年龄相关性黄斑变性 (AMD) 动物模型
- 批准号:
7481783 - 财政年份:2008
- 资助金额:
$ 40.22万 - 项目类别:
MT1-MMP-based Animal Model of Age-related Macular Degeneration (AMD)
基于 MT1-MMP 的年龄相关性黄斑变性 (AMD) 动物模型
- 批准号:
8101435 - 财政年份:2008
- 资助金额:
$ 40.22万 - 项目类别:
A novel molecular paradigm of age-related macular degeneration in view of the social trend in nocturnal: An approach using an animal model
鉴于夜间活动的社会趋势,年龄相关性黄斑变性的新分子范式:使用动物模型的方法
- 批准号:
20791248 - 财政年份:2008
- 资助金额:
$ 40.22万 - 项目类别:
Grant-in-Aid for Young Scientists (B)